m6A modification of circSPECC1 suppresses RPE oxidative damage and maintains retinal homeostasis

Xue Chen,Ying Wang,Jia-Nan Wang,Qiu-Chen Cao,Ru-Xu Sun,Hong-Jing Zhu,Ye-Ran Zhang,Jiang-Dong Ji,Qing-Huai Liu

DOI: https://doi.org/10.1016/j.celrep.2022.111671

IF: 8.8

2022-11-16

Cell Reports

Abstract:Age-related macular degeneration (AMD) is a leading cause of irreversible vision loss in the elderly population with unclear pathogenic mechanism. Herein, we detect downregulated circSPECC1 expression in retinal pigment epithelium (RPE) of AMD patients. In RPE cells, circSPECC1 insufficiency leads to oxidative stress-induced ferroptosis, depolarization, and irregular lipid metabolism. Consistently, in mice, circSPECC1 deficiency induces visual impairments and RPE anomalies and interrupts retinal homeostasis. Mechanically, nuclear export of circSPECC1 transcript depends on its N 6 -methyladenosine (m 6 A) level with YTHDC1 as the reader. CircSPECC1 directly sponges miR-145-5p to block its interaction with CDKN1A. Overexpressing miR-145-5p aggravates RPE dysfunctions, mimicking circSPECC1 silencing effects. Retinal phenotypes induced by circSPECC1 insufficiency are alleviated by miR-145-5p inhibition and are aggravated by miR-145-5p overexpression. Collectively, circSPECC1, mediated by m 6 A modification and sponging miR-145-5p, resists oxidative stress injuries and maintains lipid metabolism in RPE. Pharmacological supplementation of circSPECC1 is a promising therapeutic option for atrophic retinopathies like AMD. Introduction Age-related macular degeneration (AMD), as a worldwide leading cause for irreversible vision loss in people aged over 55, affects the macula and progressively extends to larger areas of the posterior retina (Bressler, 2004 Bressler N.M. Age-related macular degeneration is the leading cause of blindness. JAMA. 2004; 291 : 1900-1901 Crossref PubMed Scopus (528) Google Scholar ; Jager et al., 2008 Jager R.D. Mieler W.F. Miller J.W. Age-related macular degeneration. N. Engl. J. Med. 2008; 358 : 2606-2617 Crossref PubMed Scopus (1190) Google Scholar ; Lim et al., 2012 Lim L.S. Mitchell P. Seddon J.M. Holz F.G. Wong T.Y. Age-related macular degeneration. Lancet. 2012; 379 : 1728-1738 Full Text Full Text PDF PubMed Google Scholar ). Late stages of AMD can be categorized into exudative and atrophic forms depending on the presence or absence of choroidal neovascularization. Atrophic AMD is typified by sub-retinal pigment epithelium (RPE) deposits, termed drusen, at the early stage, and loss of RPE, choriocapillaris, and photoreceptors at the advanced stage (Jager et al., 2008 Jager R.D. Mieler W.F. Miller J.W. Age-related macular degeneration. N. Engl. J. Med. 2008; 358 : 2606-2617 Crossref PubMed Scopus (1190) Google Scholar ). No effective treatment has been developed for atrophic AMD, and its precise mechanism has not been fully elucidated. RPE is the major site of pathological alterations in AMD (Bok, 1993 Bok D. The retinal pigment epithelium: a versatile partner in vision. J. Cell Sci. 1993; 17 : 189-195 Crossref Google Scholar ; Marmorstein, 2001 Marmorstein A.D. The polarity of the retinal pigment epithelium. Traffic. 2001; <s -Abstract Truncated-

cell biology